value investor journal

Quote from indo:

praetorian,


my methodology to win the race is to always be steady and sound. Much like that race between the tortoise and the rabbit:D



Im not here to scalp 2% a day but rather make a low double-digit return annually.
More...

I aim for a few hundred % a year. I agree though, you have to avoid those drawdowns. DDN was another micro company that has been a powerhouse this year. My basis is 2.25.
 
Quote from indo:

a company which has a great reputation for executing in the past and still has great prospects in the future yet trades close to its historically low multiple is CHEAP to me.




example, Johnson and johnson
More...

JNJ is hardly cheap. Looking into the future, their stent products are inferior and the government is about to crack down on some of their other core businesses. That is why it is at a below historic multiple. Still, you can buy the same growth at 1/3 the multiple.

If you like stents, look at CTE, theirs will cook the JNJ ones. I have no CTE position.
 
i totally agree with you, the fundamental aspects of an organization are utmost important. I am merely going after companies which will appreciate in the future and also give out great dividend while i wait a bit.


My hopes are not to get instantaneously rich but to grow my assets over time. Im 23 years old so yes i have a longtime before i retire.
 
Quote from praetorian2:



I aim for a few hundred % a year. I agree though, you have to avoid those drawdowns. DDN was another micro company that has been a powerhouse this year. My basis is 2.25.
More...

thats a nice one. maybe you could drop a few ideas here also and we can get a longer term thread to keep going. not everyone on elite scalps.
 
Jnj are obviously facing challenges thus the stock is historically at a low multiple. However stents are not its only business and it has near monopoly power in many segments it operates in. Furthermore, JNJ has one of the soundest pipelines in the industry which will be the key for future growth.


I might be wrong but investing requires risk and i have studied the company enough to take this risk.
 
Quote from vhehn:



thats a nice one. maybe you could drop a few ideas here also and we can get a longer term thread to keep going. not everyone on elite scalps.
More...

I have been asking for a good list for a long time. Unfortunately, we end up mostly with crap on thse boards. If you want a great site, definately look at http://www.valueinvestorsclub.com

I posted DDN there at 2.8 and PTSX at 2.5. I feel odd posting them here though b/c I am not trying to do a pump and dump so I only mention them once they have moved too much so that they are not in an area where I would be a buyer.

I think the VIC guys are more discriminating and not out to go and buy size of a penny cap without a lot of research. If you want to start sharing stuff, I am all for it. But we would need basically a board for every company and then answer there for that company. Otherwise, the board will just become hopelessly garbled if we are talking about 20 stocks at once.
 
Quote from indo:

Jnj are obviously facing challenges thus the stock is historically at a low multiple. However stents are not its only business and it has near monopoly power in many segments it operates in. Furthermore, JNJ has one of the soundest pipelines in the industry which will be the key for future growth.


I might be wrong but investing requires risk and i have studied the company enough to take this risk.
More...

You may be right, but I would give the stent business no value, or even negative value. I like to take risks too, but when dealing with the government and price regulation, I am scared. They are unpredictable, especially with an election comming up. If they do something outlandish, the pipeline could be worthless as well. That at least is why I prefer to just avoid pharma and health care. I guess that you probably have a better feeling on the risks in our government so then it makes sense to go picking around in that area.
 
Quote from praetorian2:



You may be right, but I would give the stent business no value, or even negative value. I like to take risks too, but when dealing with the government and price regulation, I am scared. They are unpredictable, especially with an election comming up. If they do something outlandish, the pipeline could be worthless as well. That at least is why I prefer to just avoid pharma and health care. I guess that you probably have a better feeling on the risks in our government so then it makes sense to go picking around in that area.
More...

agree. i prefer to play drugs with leaps because of this. jnj nearing strong support at 49. i will buy some 06 40 leaps when \if it hits 49.
 
Quote from onewaypockets:

VZ is down 5.17% from your position.

Wondering where your stop is.
More...

vz has several problems hurting its stock.
1.it just signed a very expensive labor contract.
2.they sell a commodity product that has no pricing power.
3.mci will come out of bankruptcy without any debt and without any union contracts and no dividend to pay and eat their lunch.
 
You must log in or register to reply here.
Back
Top